Format

Send to

Choose Destination
See comment in PubMed Commons below
J Ethn Subst Abuse. 2010;9(2):106-14. doi: 10.1080/15332641003772587.

Association of race and ethnicity with withdrawal symptoms, attrition, opioid use, and side-effects during buprenorphine therapy.

Author information

1
Department of Psychiatry, The University of Texas Southwestern Medical Center, Dallas, Texas 75390-8849, USA. Sherwood.Brown@UTSouthwestern.edu

Abstract

Some studies report differences in opioid withdrawal between racial/ethnic groups. However, it is not known if these differences are reflected in differential treatment response. Data from National Institute on Drug Abuse (NIDA) Clinical Trials Network-003 were used to examine racial/ethnic differences before and during stabilization with buprenorphine. At induction, non-Hispanic Caucasians had higher objective and subjective withdrawal scores and greater opioid craving than minority participants. No significant between-group differences were observed on these scales following buprenorphine. Non-Hispanic Caucasians and Hispanics reported more adverse events than African Americans. Although ethnic and racial differences were observed prior to buprenorphine treatment, scores following buprenorphine treatment were similar between groups.

PMID:
20509084
PMCID:
PMC3176716
DOI:
10.1080/15332641003772587
[Indexed for MEDLINE]
Free PMC Article
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for PubMed Central
    Loading ...
    Support Center